These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

374 related articles for article (PubMed ID: 33436426)

  • 1. Same Game, Different Players: Emerging Pathogens of the CF Lung.
    Gannon AD; Darch SE
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436426
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.
    Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB
    mBio; 2020 Jun; 11(3):. PubMed ID: 32576671
    [No Abstract]   [Full Text] [Related]  

  • 3.
    Orazi G; O'Toole GA
    mBio; 2017 Jul; 8(4):. PubMed ID: 28720732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Airway Microbiome and Inflammation with Ivacaftor Treatment in Patients with Cystic Fibrosis and the G551D Mutation.
    Harris JK; Wagner BD; Zemanick ET; Robertson CE; Stevens MJ; Heltshe SL; Rowe SM; Sagel SD
    Ann Am Thorac Soc; 2020 Feb; 17(2):212-220. PubMed ID: 31604026
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutual Effects of Single and Combined CFTR Modulators and Bacterial Infection in Cystic Fibrosis.
    Cigana C; Giannella R; Colavolpe A; Alcalá-Franco B; Mancini G; Colombi F; Bigogno C; Bastrup U; Bertoni G; Bragonzi A
    Microbiol Spectr; 2023 Feb; 11(1):e0408322. PubMed ID: 36625583
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Touré H; Herrmann J-L; Szuplewski S; Girard-Misguich F
    Infect Immun; 2023 Nov; 91(11):e0024023. PubMed ID: 37847031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspergillus infections in cystic fibrosis.
    King J; Brunel SF; Warris A
    J Infect; 2016 Jul; 72 Suppl():S50-5. PubMed ID: 27177733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low Diversity and Instability of the Sinus Microbiota over Time in Adults with Cystic Fibrosis.
    Armbruster CR; Li K; Kiedrowski MR; Zemke AC; Melvin JA; Moore J; Atteih S; Fitch AC; DuPont M; Manko CD; Weaver ML; Gaston JR; Alcorn JF; Morris A; Methé BA; Lee SE; Bomberger JM
    Microbiol Spectr; 2022 Oct; 10(5):e0125122. PubMed ID: 36094193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cystic fibrosis lung environment and Pseudomonas aeruginosa infection.
    Bhagirath AY; Li Y; Somayajula D; Dadashi M; Badr S; Duan K
    BMC Pulm Med; 2016 Dec; 16(1):174. PubMed ID: 27919253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving outcomes of infections in cystic fibrosis in the era of CFTR modulator therapy.
    Saiman L
    Pediatr Pulmonol; 2019 Nov; 54 Suppl 3():S18-S26. PubMed ID: 31715086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron acquisition in the cystic fibrosis lung and potential for novel therapeutic strategies.
    Tyrrell J; Callaghan M
    Microbiology (Reading); 2016 Feb; 162(2):191-205. PubMed ID: 26643057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of Cross-Feeding Inhibits Pathogen Growth in the Sputa of Patients with Cystic Fibrosis.
    Flynn JM; Cameron LC; Wiggen TD; Dunitz JM; Harcombe WR; Hunter RC
    mSphere; 2020 Apr; 5(2):. PubMed ID: 32350096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refining the Application of Microbial Lipids as Tracers of Staphylococcus aureus Growth Rates in Cystic Fibrosis Sputum.
    Neubauer C; Kasi AS; Grahl N; Sessions AL; Kopf SH; Kato R; Hogan DA; Newman DK
    J Bacteriol; 2018 Dec; 200(24):. PubMed ID: 30249710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Pathogen Eradication" and "Emerging Pathogens": Difficult Definitions in Cystic Fibrosis.
    Gilligan PH; Downey DG; Elborn JS; Flume PA; Funk S; Gilpin D; Kidd TJ; McCaughan J; Millar BC; Murphy PG; Rendall JC; Tunney MM; Moore JE
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 29875191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Staphylococcus aureus in cystic fibrosis: pivotal role or bit part actor?
    Hurley MN; Smyth AR
    Curr Opin Pulm Med; 2018 Nov; 24(6):586-591. PubMed ID: 30113336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of multispecies social interactions in shaping Pseudomonas aeruginosa pathogenicity in the cystic fibrosis lung.
    O'Brien S; Fothergill JL
    FEMS Microbiol Lett; 2017 Aug; 364(15):. PubMed ID: 28859314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early detection of non-tuberculous mycobacteria in children with cystic fibrosis using induced sputum at annual review.
    Ahmed MI; Kulkarni H; Shajpal S; Patel D; Patel P; Claydon A; Modha DE; Gaillard EA
    Pediatr Pulmonol; 2019 Mar; 54(3):257-263. PubMed ID: 30561865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial Culture Underestimates Lung Pathogen Detection and Infection Status in Cystic Fibrosis.
    Gavillet H; Hatfield L; Rivett D; Jones A; Maitra A; Horsley A; van der Gast C
    Microbiol Spectr; 2022 Oct; 10(5):e0041922. PubMed ID: 35972283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Staphylococcus aureus in cystic fibrosis pathogenesis and clinico-microbiological interactions.
    Sheykhsaran E; Abbasi A; Memar MY; Ghotaslou R; Baghi HB; Mazraeh FN; Laghousi D; Sadeghi J
    Diagn Microbiol Infect Dis; 2024 Jul; 109(3):116294. PubMed ID: 38678689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microbiome in cystic fibrosis: Shaping polymicrobial interactions for advances in antibiotic therapy.
    Lopes SP; Azevedo NF; Pereira MO
    Crit Rev Microbiol; 2015; 41(3):353-65. PubMed ID: 24645634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.